Publication:
Topically applied azaphenothiazines inhibit contact sensitivity to oxazolone in mice

Loading...
Thumbnail Image
Date
2018
relationships.isAuthorOfPublication
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Artym, Jolanta ; Kocięba, Maja ; Zaczyńska, Ewa ; Zimecki, Michał ; Jeleń, Małgorzata ; Morak Młodawska, Beata ; Pluta, Krystian ; Kaleta Kuratewicz, Katarzyna ; Madej, Jan P. ; Kuropka, Piotr ; Kuryszko, Jan
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia. Departamento de Biología Celular e Histología
publication.page.editor
publication.page.department
DOI
DOI: 10.14670/HH-11-921
item.page.type
info:eu-repo/semantics/article
Description
Abstract
In this work we investigated the efficacy of two topically applied azaphenothiazine derivatives, 9- c h l o r o - 6 - a c e t y l ami n o b u t y l q u i n o b e n z o [ 3 , 2 - b][1,4]thiazine (compound 4) and 6-chloroethylureidoethyldiquino[3,2-b;2’;3’-e][1,4]thiazine (compound 5), in the amelioration of inflammatory symptoms of contact sensitivity (CS) to oxazolone in mice, in relation to the commercial ointment Protopic® (tacrolimus), the reference drug. The compounds were administered 24 h following elicitation of CS and, 24 h later, the parameters of inflammation, such as ear edema, blood composition, leukocyte level, numbers of cells in the draining lymph nodes, histological picture of the inflamed tissue, and the morphometric analysis, were analyzed. The study showed that the effectiveness of the studied azaphenothiazines applied as a 0.1% ointment was comparable to the reference drug regarding suppression of the inflammatory process, when all the investigated histological parameters are taken into account.
Citation
Histology and Histopathology, Vol.33, nº2, (2018)
item.page.embargo